In pursuit of better care for more people, we partner with physicians and institutions worldwide to discover what’s next in treating the challenges of cardiovascular health. We are dedicated to supporting investigator-initiated research because we believe that through research and discovery, we advance patient care together.
Thank you for your interest in submitting an IIR application. Below are the simple application steps to request support / funding:
Step 1: Complete and submit IIR application. You can save your progress and log back in to finish if necessary.
Step 2: The following documents are required for submission. Please provide in a PDF format, attaching to your application:
Once submitted, the application is reviewed for completeness.
If the IIR request meets the initial requirements, the approval process begins with a scientific review to ensure merit, significance, and available funding. If accepted, the IIR application will be sent to the Grant Committee for legal and regulatory review.
The applicant will be contacted directly once a Grant Committee decision is made. Updates will be provided to the applicant throughout the review process.
If you still have questions after reviewing the content on this site, please contact us at IIRStudy.IGTDevices@philips.com.
We mindfully review all IIR study requests with a detailed assessment by a cross-functional team. IIR Requests will be assessed with the following criteria:
Text:
Industry sponsored | Investigator sponsored | |
Protocol ownership | The company owns the protocol and invites investigators to participate | The sponsor institute owns the protocol and can submit multiple funding sources for support |
Data | The company manages data with subject consent; the investigator typically has access to their data only | The sponsor institute manages data with subject consent and gives company rights to use the data |
Monitoring | The company is responsible for conducting appropriate monitoring and may monitor the data to ensure validity | The sponsor institute is responsible for study conduct and data validity |
Intellectual Property | The company typically has rights to all intellectual property developed from the study data | The intellectual property is negotiated by study protocol |
Deliverables | Usually determined by the company | The investigator and company determine as part of any research grant agreement |
Publication | The company and steering committee determine authorship | The investigator determines authorship |
Definitions:
Sponsor | Principal Investigator (PI) |
An individual, company, institution, or organization that takes responsibility for the initiation, management, and / or financing of a clinical trial. Note: The regulatory/legal definitions of "Sponsor" and associated indicators of sponsorship may vary by geography. | An individual who is responsible and accountable for conducting the study at a study site. The Pl assumes full responsibility for the treatment and evaluation of the Clinical Subjects and for the integrity of the research data and results at the respective study site. Note: The Principal Investigator may also be the Sponsor of the clinical study. |
Responsibilities:
Sponsor (ISO 14155):
Principal investigator (ISO 14155):
The role of the principal investigator is to implement and manage the day-to-day conduct of the clinical investigation as well as ensure data integrity and the rights, safety and well-being of the subjects involved in the clinical investigation. Understand and act in accordance with FDA, MedTech, Eudamed (European Commission) (pending 2022) requirements, local, laws, and guidelines.
If you have questions about the IIR Principal Investigator/Site Roles and Responsibilities, please contact us at IIRStudy.IGTDevices@philips.com.
Philips Image Guided Therapy Devices (IGTD) will consider all relevant research proposals that meet the IIR study criteria. Please find examples of Philips’ IGTD current areas of interest below.
Note: Funding is limited. Support for studies will be considered from both a scientific and financial lens.
Peripheral Vasculature
Peripheral artery disease and peripheral venous disease treatment and visual guidance including:
Interventional Cardiology
Clinical and economic outcomes of Philips imaging, physiology, and/or therapeutic tools in CAD including:
Heart Rhythm Management
Click here to launch the Image-guided therapy devices IIR application.